Evidence map›Paper›PMID 39139039›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2024

Liver kinase B1 (LKB1) regulates the epigenetic landscape of mouse pancreatic beta cells.

Nejc Haberman, Rebecca Cheung, Grazia Pizza, Nevena Cvetesic, Dorka Nagy, Hannah Maude, Lorea Blazquez, Boris Lenhard, Inês Cebola, Guy A Rutter and 1 more

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Nejc HabermanMRC London Institute of Medical Sciences, London, UK.ORCID 0000-0001-9247-4139
Rebecca CheungSection of Cell Biology and Functional Genomics, Faculty of Medicine, Imperial College London, London, UK.
Grazia PizzaSection of Cell Biology and Functional Genomics, Faculty of Medicine, Imperial College London, London, UK.
Nevena CvetesicMRC London Institute of Medical Sciences, London, UK.ORCID 0000-0002-1575-5612
Dorka NagySection of Genetics and Genomics, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.ORCID 0000-0002-5373-9664
Hannah MaudeSection of Genetics and Genomics, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.ORCID 0000-0002-7593-4516
Lorea BlazquezDepartment of Neurosciences, Biogipuzkoa Health Research Institute, San Sebastián, Spain.ORCID 0000-0003-2885-3286
Boris LenhardMRC London Institute of Medical Sciences, London, UK.ORCID 0000-0002-1114-1509
Inês CebolaSection of Genetics and Genomics, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.ORCID 0000-0003-3528-4982
Guy A RutterSection of Cell Biology and Functional Genomics, Faculty of Medicine, Imperial College London, London, UK.ORCID 0000-0001-6360-0343
Aida Martinez-SanchezSection of Cell Biology and Functional Genomics, Faculty of Medicine, Imperial College London, London, UK.ORCID 0000-0001-5142-2527

Funding

Understanding putative beta-cell subtypesR01DK139630 · NIDDK · VAN ANDEL RESEARCH INSTITUTE · PI John Andrew Pospisilik · 2024 to 2026
$2.7M
Control of insulin secretion by mitochondrial fusionR01DK135268 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Brett A Kaufman, Scott Soleimanpour · 2023 to 2026
$2.4M
British Heart Foundation (BHF) FS/4yPhD/F/20/34128Canada Foundation for Innovation CFI 42649Canadian Government | Canadian Institutes of Health Research (CIHR) CIHR-IRSC:0682002550Diabetes UK BDA16/0005485Ikerbasque, Basque Foundation for Science RF/2019/001JDRF (JDRF International) JDRF 4-SRA-2023-1182-S-NMEC | Instituto de Salud Carlos III (ISCIII) PI19/00468RYC2018-024397-INIDDK NIH HHS R01 DK135268NIDDK NIH HHS R01 DK139630UKRI | Medical Research Council (MRC) MC_UP_1102/1UKRI | Medical Research Council (MRC) MR/P023223/1UKRI | Medical Research Council (MRC) MR/X009912/1Wellcome TrustWellcome Trust (WT) 212625/Z/18/ZWellcome Trust (WT) 224662/Z/21/Z
6 · The paper itself

Abstract

Liver kinase B1 (LKB1/STK11) is an important regulator of pancreatic β-cell identity and function. Elimination of Lkb1 from the β-cell results in improved glucose-stimulated insulin secretion and is accompanied by profound changes in gene expression, including the upregulation of several neuronal genes. The mechanisms through which LKB1 controls gene expression are, at present, poorly understood. Here, we explore the impact of β cell-selective deletion of Lkb1 on chromatin accessibility in mouse pancreatic islets. To characterize the role of LKB1 in the regulation of gene expression at the transcriptional level, we combine these data with a map of islet active transcription start sites and histone marks. We demonstrate that LKB1 elimination from β-cells results in widespread changes in chromatin accessibility, correlating with changes in transcript levels. Changes occurred in hundreds of promoter and enhancer regions, many of which were close to neuronal genes. We reveal that dysregulated enhancers are enriched in binding motifs for transcription factors (TFs) important for β-cell identity, such as FOXA, MAFA or RFX6, and we identify microRNAs (miRNAs) that are regulated by LKB1 at the transcriptional level. Overall, our study provides important new insights into the epigenetic mechanisms by which LKB1 regulates β-cell identity and function.

Indexed as

Epigenesis, GeneticInsulin-Secreting CellsProtein Serine-Threonine KinasesAMP-Activated Protein KinasesAnimalsMaleMiceMice, Inbred C57BLMice, KnockoutMicroRNAsPromoter Regions, GeneticAMP-Activated Protein KinasesMicroRNAsProtein Serine-Threonine KinasesStk11 protein, mouse

Identifiers

PMID39139039
PMCPMC11378476

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.